JAZZ PHARMACEUTICALS PLC (JAZZ) Stock Analyst Earnings Estimates
NASDAQ:JAZZ - Nasdaq - IE00B4Q5ZN47 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.659B 18.27% | 3.834B 4.78% | 4.069B 6.12% | 4.317B 6.10% | 4.536B 5.07% | 4.843B 6.77% | 5.136B 6.05% | 5.416B 5.45% | 5.289B -2.34% | 5.164B -2.36% | 5.271B 2.07% | |
| EBITDA YoY % growth | 738.4M -22.42% | 1.317B 78.37% | 1.387B 5.29% | 786.59M -43.28% | 1.941B 146.76% | 2.065B 6.39% | 2.402B 16.32% | 2.554B 6.33% | 2.249B -11.94% | 2.199B -2.22% | 2.125B -3.37% | |
| EBIT YoY % growth | 108.9M -72.73% | 678.38M 522.94% | 726.63M 7.11% | 684.88M -5.75% | 1.821B 165.89% | 1.947B 6.92% | 2.094B 7.55% | 2.237B 6.83% | 1.92B -14.17% | 1.644B -14.37% | 1.614B -1.82% | |
| Operating Margin | 2.98% | 17.69% | 17.86% | 15.86% | 40.15% | 40.20% | 40.77% | 41.30% | 36.30% | 31.84% | 30.62% | |
| EPS YoY % growth | 13.13 -19.10% | 18.32 39.53% | 21.19 15.67% | 4.86 -77.07% | 22.02 353.19% | 23.80 8.09% | 26.13 9.80% | 28.51 9.10% | 25.38 -10.96% | 20.08 -20.90% | 19.82 -1.30% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.14 -22.23% | 5.42 -17.89% | 4.81 186.12% | 5.45 166.10% | 5.79 12.57% | 6.82 25.92% |
| Revenue Q2Q % growth | 1.125B 6.64% | 1.186B 8.99% | 1.008B 12.27% | 1.087B 3.95% | 1.137B 1.07% | 1.224B 3.20% |
| EBITDA Q2Q % growth | 505.21M -32.81% | 488.02M -42.64% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 490.51M 88.51% | 497.86M 160.97% | 370.06M 762.10% | 446.05M 103.70% | 468.59M -4.47% | 473.59M -4.87% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -8.25 -255.66% | -7.76 | -0.49 | -6.35% |
| Q1 2025 Q2Q % growth | 1.68 -37.31% | 4.75 | -3.07 | -64.64% |
| Q4 2024 Q2Q % growth | 6.60 31.47% | 5.93 | 0.67 | 11.32% |
| Q3 2024 Q2Q % growth | 6.61 36.57% | 5.61 | 1.00 | 17.85% |
| Q2 2024 Q2Q % growth | 5.30 17.52% | 4.87 | 0.43 | 8.88% |
| Q1 2024 Q2Q % growth | 2.68 -32.15% | 4.26 | -1.58 | -37.13% |
| Q4 2023 Q2Q % growth | 5.02 7,271.43% | 5.29 | -0.27 | -5.07% |
| Q3 2023 Q2Q % growth | 4.84 -6.38% | 5.03 | -0.19 | -3.79% |
| Q2 2023 Q2Q % growth | 4.51 4.88% | 4.52 | -0.01 | -0.23% |
| Q1 2023 Q2Q % growth | 3.95 5.90% | 4.32 | -0.37 | -8.66% |
| Q4 2022 Q2Q % growth | -0.07 -101.66% | 0.33 | -0.40 | -121.41% |
| Q3 2022 Q2Q % growth | 5.17 23.10% | 4.75 | 0.42 | 8.75% |
| Q2 2022 Q2Q % growth | 4.30 10.26% | 4.28 | 0.02 | 0.58% |
| Q1 2022 Q2Q % growth | 3.73 -4.85% | 3.92 | -0.19 | -4.77% |
| Q4 2021 Q2Q % growth | 4.21 5.25% | 3.72 | 0.49 | 13.31% |
| Q3 2021 Q2Q % growth | 4.20 -2.55% | 3.38 | 0.82 | 24.08% |
| Q2 2021 Q2Q % growth | 3.90 5.12% | 3.50 | 0.40 | 11.45% |
| Q1 2021 Q2Q % growth | 3.92 771.11% | 3.79 | 0.13 | 3.53% |
| Q4 2020 Q2Q % growth | 4.00 -9.50% | 4.29 | -0.29 | -6.69% |
| Q3 2020 Q2Q % growth | 4.31 5.12% | 4.16 | 0.15 | 3.67% |
| Q2 2020 Q2Q % growth | 3.71 -8.40% | 3.17 | 0.54 | 16.86% |
| Q1 2020 Q2Q % growth | 0.45 -87.74% | 0.69 | -0.24 | -34.35% |
| Q4 2019 Q2Q % growth | 4.42 | 4.20 | 0.22 | 5.16% |
| Q3 2019 Q2Q % growth | 4.10 | 3.67 | 0.43 | 11.81% |
| Q2 2019 Q2Q % growth | 4.05 | 3.64 | 0.41 | 11.18% |
| Q1 2019 Q2Q % growth | 3.67 | 3.22 | 0.45 | 13.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.046B 2.14% | 1.068B | -22.29M | -2.09% |
| Q1 2025 Q2Q % growth | 897.841M -0.46% | 1.005B | -107.159M | -10.66% |
| Q4 2024 Q2Q % growth | 1.088B 7.53% | 1.081B | 7.173M | 0.66% |
| Q3 2024 Q2Q % growth | 1.055B 8.52% | 1.057B | -2.031M | -0.19% |
| Q2 2024 Q2Q % growth | 1.024B 6.95% | 1.024B | -175K | -0.02% |
| Q1 2024 Q2Q % growth | 901.983M 1.03% | 972.97M | -70.987M | -7.30% |
| Q4 2023 Q2Q % growth | 1.012B 4.10% | 1.021B | -9.065M | -0.89% |
| Q3 2023 Q2Q % growth | 972.14M 3.34% | 985.21M | -13.07M | -1.33% |
| Q2 2023 Q2Q % growth | 957.317M 2.62% | 961.72M | -4.403M | -0.46% |
| Q1 2023 Q2Q % growth | 892.812M 9.72% | 913.34M | -20.528M | -2.25% |
| Q4 2022 Q2Q % growth | 972.1M 8.41% | 995.11M | -23.01M | -2.31% |
| Q3 2022 Q2Q % growth | 940.7M 12.24% | 957.84M | -17.14M | -1.79% |
| Q2 2022 Q2Q % growth | 932.9M 24.09% | 922.3M | 10.6M | 1.15% |
| Q1 2022 Q2Q % growth | 813.7M 33.92% | 869.81M | -56.11M | -6.45% |
| Q4 2021 Q2Q % growth | 896.7M 34.74% | 881.51M | 15.19M | 1.72% |
| Q3 2021 Q2Q % growth | 838.1M 39.47% | 849.17M | -11.07M | -1.30% |
| Q2 2021 Q2Q % growth | 751.8M 33.68% | 754.36M | -2.56M | -0.34% |
| Q1 2021 Q2Q % growth | 607.6M 13.63% | 620.41M | -12.81M | -2.06% |
| Q4 2020 Q2Q % growth | 665.5M 14.41% | 652.34M | 13.16M | 2.02% |
| Q3 2020 Q2Q % growth | 600.9M 11.75% | 589.13M | 11.77M | 2.00% |
| Q2 2020 Q2Q % growth | 562.4M 5.30% | 514.75M | 47.65M | 9.26% |
| Q1 2020 Q2Q % growth | 534.7M 5.21% | 555.44M | -20.74M | -3.73% |
| Q4 2019 Q2Q % growth | 581.7M | 573.26M | 8.44M | 1.47% |
| Q3 2019 Q2Q % growth | 537.7M | 534.88M | 2.82M | 0.53% |
| Q2 2019 Q2Q % growth | 534.1M | 518.79M | 15.31M | 2.95% |
| Q1 2019 Q2Q % growth | 508.2M | 475.27M | 32.93M | 6.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.18% | -17.47% | 0% | -79.56% |
| Revenue | 0.45% | 0.81% | 0.09% | -1.39% |